Search Results
Oct 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in the Securities of Spirit Aviation Holdings, Inc. - FLYYQ
obligations; (ii) Spirit was also at substantial risk of being forced to file for Chapter 11 bankruptcy protection within a mere matter of months; (iii) accordingly, Defendants had overstated enhancements to Spirit's financial condition, liquidity, and overall business and operations, while simultaneously
More news about: Pomerantz LLP
Oct 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
regarding MOLBREEVI's chemistry, manufacturing, and/or controls; (ii) accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form; (iii) the foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors;
More news about: Pomerantz LLP
Oct 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN
meaningfully explore the foregoing offer and failed to disclose its terms when recommending that Cepton's shareholders approve the Koito Acquisition; (iii) consequently, Cepton's shareholders were deprived of the opportunity to meaningfully consider whether to accept or reject the Koito Acquisition; and
More news about: Pomerantz LLP
Oct 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company's products, including briquilimab; (iii) the foregoing increased the likelihood of disruptive cost-reduction measures; (iv) accordingly, the Company's business and/or financial prospects, as
More news about: Pomerantz LLP
Oct 23, 2025, 09:21 ET METiS BioTech announces China's First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial
years to under 3 months. From program initiation to Phase III completion, MTS-004 completed a full development cycle of in months, significantly accelerating the path from discovery to clinical validation. The Phase III trial was led by Professor Dongsheng FAN, Chair of Neurology
More news about: METiS TechBio
Oct 23, 2025, 08:52 ET Learning Ally Co-Sponsors Washington, D.C. Screening of Left Behind -- A Documentary Celebrating the Fight for Dyslexia Equity
the Martin Luther King Jr. Memorial Library in Washington, D.C. The evening will begin with a special introduction by Learning Ally CEO Howard Bell III. The screening will be followed by a panel discussion featuring the film's director, award-winning educator and community advocate Kareem Weaver, and
More news about: Learning Ally
Oct 23, 2025, 08:45 ET Savara Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 7, 2025 to Discuss Your Rights - SVRA
regarding MOLBREEVI's chemistry, manufacturing, and/or controls; (ii) accordingly, FDA was unlikely to approve the MOLBREEVI BLA in its current form; (iii) foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors; (iv)
More news about: The Gross Law Firm
Oct 23, 2025, 08:45 ET Shareholders that lost money on Dow Inc.(DOW) should contact The Gross Law Firm about pending Class Action - DOW
pricing pressures, softening global sales and demand for the Company's products, and an oversupply of products in the Company's global markets; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times. DEADLINE:
More news about: The Gross Law Firm
Oct 23, 2025, 08:45 ET November 14, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against FLR
hesitation around economic uncertainty, was having, or was likely to have, a significant negative impact on the Company's business and financial results; (iii) accordingly, Fluor's financial guidance for FY 2025 was unreliable and/or unrealistic, the effectiveness of the Company's risk mitigation strategy was
More news about: The Gross Law Firm
Oct 23, 2025, 08:43 ET THE REPUBLIC OF SURINAME ANNOUNCES AN INVITATION FOR OFFERS TO TENDER FOR CASH ITS 7.95% CASH/PIK SECURITIES DUE 2033
Order"), (ii) who fall within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.") of the Financial Promotion Order, (iii) who are outside the UK, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of
More news about: The Republic of Suriname
Oct 23, 2025, 08:30 ET A1R WATER and Southern Glazer's Wine & Spirits National Distribution Agreement
Inflection Point Acquisition Corp. III, a publicly traded special purpose acquisition company (Nasdaq: IPCX). Upon closing of the business combination, the combined company will be named
More news about: Air Water Ventures Holdings Ltd.
Oct 23, 2025, 08:07 ET All-in-One CRO Solution Lindus Health Welcomes Heather Davis as Vice President of US Clinical Operations
pivotal Phase III, 200-participant trial with
More news about: Lindus Health
Oct 23, 2025, 08:05 ET Cetera Welcomes Oestriecher Financial Management with $154 Million in AUA to its Avantax Community of Tax-Focused Advisors
Founded in 1999 as an extension of the accounting practice established by Anne Oestriecher's father, Emile P. "Mr. O" Oestriecher III, CPA, OFMS has become known in Central Louisiana for building trusted, multigenerational client relationships. The firm was affiliated with HD Vest,
More news about: Cetera Financial Group
Oct 23, 2025, 08:00 ET Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo's business, (iii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, including
More news about: Ginkgo Bioworks
Oct 23, 2025, 08:00 ET Astellas and the Internet's Favorite Grandma, Barbara 'Babs' Costello, Partner to Encourage Others to Get Ahead of Geographic Atrophy (GA)
(i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue
More news about: Astellas Pharma Inc.
Oct 23, 2025, 07:49 ET REPUBLIC OF URUGUAY - ANNOUNCEMENT OF GLOBAL TENDER OFFER RESULTS
cancellation of your tender and in your remaining obligated to purchase your allocation of New Bonds in respect of your related indication of interest and/or (iii) in the delivery of a buy-in notice for the purchase of such Old Global Bonds, executed in accordance with customary brokerage practices for corporate
More news about: Republic of Uruguay
Oct 23, 2025, 07:32 ET Verde's Next-Gen Carbon Sequestering BioAsphalt™ Exceeds Industry Specifications
license agreement with Ergon, (ii) the proposed $2 million investment by Ergon into Verde, which is not currently subject to definitive documentation, (iii) the anticipated attributes and advantages of Verde's products and (iv) Verde and Ergon's future commercial plans in general. These and other statements
More news about: Verde Resources Inc.
Oct 23, 2025, 07:25 ET Suburban Propane Partners, L.P. Declares Quarterly Distribution of $0.325 per Common Unit
federal income tax withholding at the highest applicable effective tax rate without exception. Regarding the amount realized pursuant to 1.1446(f)-4(c)(2)(iii), 100% of the distribution is in excess of cumulative net income. Brokers and nominees are treated as withholding agents responsible for withholding
More news about: Suburban Propane Partners, L.P.
Oct 23, 2025, 07:00 ET Greenbelt Capital Partners Expands Team with Senior Hires
reshaping how the world produces and consumes energy. In June of this year, the Firm announced the final close of its fund, Greenbelt Capital Partners III L.P., at $1 billion. Mrs. Kiersey, based in Texas, joins Greenbelt as Chief Strategy Officer and Operating Partner. She previously
More news about: Greenbelt Capital Partners
Oct 23, 2025, 06:55 ET Visteon Delivers Strong Third Quarter 2025 Margin Expansion and Cash Generation
and the effects of any restructuring or reorganization plans that may be undertaken by our customers, including work stoppages at our customers, and (iii) possible disruptions in the supply of commodities to us or our customers due to financial distress, work stoppages, natural disasters or civil unrest;
More news about: Visteon Corporation
Oct 23, 2025, 06:50 ET Forklift Trucks Market Forecast at $88Bn as Warehouse Automation & E-Commerce Expansion Drive Growth to 2030, Says Mordor Intelligence
Class I (Electric Rider Trucks) Class II (Electric Narrow-Aisle) Class III (Electric Pallet) Class IV (ICE Cushion-Tire) Class V (ICE Pneumatic-Tire)
More news about: Mordor Intelligence Private Limited
Oct 23, 2025, 06:30 ET G Mining Ventures Announces Formal Construction Decision for the Oko West Gold Project and Provides Project Development Update
about 1,270 jobs over the life of mine; (ii) the initial equipment deliveries being expected in Q3-2025 and enabling GMIN to start earthworks on site; (iii) and (iv) in general, the section entitled "About G Mining Ventures Corp."; as well as the quoted comments of GMIN's President
More news about: G Mining Ventures Corp
Oct 23, 2025, 06:00 ET Hyperscale Data to Launch On-Demand NVIDIA GPU Cloud from Michigan AI Campus
growth. "Through ACS, we're building a true compute marketplace — immediate, elastic, and powerful," said Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "We look forward to announcing additional customers and forming new partnerships that will strengthen our mission
More news about: Hyperscale Data Inc.
Oct 23, 2025, 03:49 ET Improved Pharma exhibiting and presenting at AAPS 2025 PHARMSCI 360
Crystallinity in Amorphous Solid Dispersions of Nilotinib". This special collection features 5 posters that were personally selected by host Bill Williams, III, Ph.D., FAAPS, University of Texas at Austin. The session is from 10:30 AM – 11:25 AM at Poster Forum 4. Each author will have approximately 10 minutes
More news about: Improved Pharma
Oct 23, 2025, 02:18 ET 最大里程碑付款到賬 一家中國醫藥MNC強勢崛起
10月中旬的歐洲腫瘤內科學會（ESMO）2025 年會，再次帶來了iza-bren的好消息。這款全球首創 EGFR×HER3 雙抗 ADC 藥物，首次報告了其關鍵註冊 III 期臨床研究的成果：該藥物在後線鼻咽癌治療核心療效指標上實現了成倍的提升。研究成果也在國際頂級醫學期刊《柳葉刀》（The Lancet）發表全文。 目前，iza-bren已在全球開展 40 余項臨床研究，其中包括10 項中國 III 期臨床註冊研究和3項海外關鍵註冊研究，中美兩國都將其中一些研究認定為「突破性療法」以加快藥物開發。這款藥物有望在2026年率先於中國上市，按計劃會早於美國三年。這對中國創新藥將是標誌性轉折事件。
More news about: Biokin